REPORT ID 3833

EMEA (Europe, Middle East and Africa) Tumor Ablation Devices Market Report 2017

Publish Date
14-Dec-17
Pages
112
Format
Electronic (PDF)

In this report, the EMEA Tumor Ablation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Tumor Ablation Devices for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Tumor Ablation Devices market competition by top manufacturers/players, with Tumor Ablation Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Ethicon
    Karl Storz
    Intuitive Surgical
    Medtronic
    Olympus
    Aesculap
    Applied Medical
    B. Braun Melsungen
    CareFusion
    Conmed
    Davol
    Encision
    Eon Surgical
    Gyrus ACMI
    Integra LifeSciences
    IMRIS

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Microwave Ablation
    Laser Ablation
    Ultrasound Ablation

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Urological Surgery
    Gynecological Surgery
    General Surgery
    Gastrointestinal Surgery
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Tumor Ablation Devices Market Report 2017
1 Tumor Ablation Devices Overview
    1.1 Product Overview and Scope of Tumor Ablation Devices
    1.2 Classification of Tumor Ablation Devices
        1.2.1 EMEA Tumor Ablation Devices Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Tumor Ablation Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Microwave Ablation
        1.2.4 Laser Ablation
        1.2.5 Ultrasound Ablation
    1.3 EMEA Tumor Ablation Devices Market by Application/End Users
        1.3.1 EMEA Tumor Ablation Devices Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Urological Surgery
        1.3.3 Gynecological Surgery
        1.3.4 General Surgery
        1.3.5 Gastrointestinal Surgery
        1.3.6 Others
    1.4 EMEA Tumor Ablation Devices Market by Region
        1.4.1 EMEA Tumor Ablation Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Tumor Ablation Devices (2012-2022)
        1.5.1 EMEA Tumor Ablation Devices Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Tumor Ablation Devices Revenue and Growth Rate (2012-2022)

2 EMEA Tumor Ablation Devices Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Tumor Ablation Devices Market Competition by Players/Manufacturers
        2.1.1 EMEA Tumor Ablation Devices Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Tumor Ablation Devices Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Tumor Ablation Devices Sale Price by Players (2012-2017)
    2.2 EMEA Tumor Ablation Devices (Volume and Value) by Type/Product Category
        2.2.1 EMEA Tumor Ablation Devices Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Tumor Ablation Devices Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Tumor Ablation Devices Sale Price by Type (2012-2017)
    2.3 EMEA Tumor Ablation Devices (Volume) by Application
    2.4 EMEA Tumor Ablation Devices (Volume and Value) by Region
        2.4.1 EMEA Tumor Ablation Devices Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Tumor Ablation Devices Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Tumor Ablation Devices Sales Price by Region (2012-2017)

3 Europe Tumor Ablation Devices (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Tumor Ablation Devices Sales and Value (2012-2017)
        3.1.1 Europe Tumor Ablation Devices Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Tumor Ablation Devices Revenue and Growth Rate (2012-2017)
    3.2 Europe Tumor Ablation Devices Sales and Market Share by Type
    3.3 Europe Tumor Ablation Devices Sales and Market Share by Application
    3.4 Europe Tumor Ablation Devices Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Tumor Ablation Devices Sales Volume by Countries (2012-2017)
        3.4.2 Europe Tumor Ablation Devices Revenue by Countries (2012-2017)
        3.4.3 Germany Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        3.4.4 France Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        3.4.5 UK Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        3.4.6 Russia Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        3.4.7 Italy Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Tumor Ablation Devices Sales and Growth Rate (2012-2017)

4 Middle East Tumor Ablation Devices (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Tumor Ablation Devices Sales and Value (2012-2017)
        4.1.1 Middle East Tumor Ablation Devices Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Tumor Ablation Devices Revenue and Growth Rate (2012-2017)
    4.2 Middle East Tumor Ablation Devices Sales and Market Share by Type
    4.3 Middle East Tumor Ablation Devices Sales and Market Share by Application
    4.4 Middle East Tumor Ablation Devices Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Tumor Ablation Devices Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Tumor Ablation Devices Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        4.4.4 Israel Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        4.4.5 UAE Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        4.4.6 Iran Tumor Ablation Devices Sales and Growth Rate (2012-2017)

5 Africa Tumor Ablation Devices (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Tumor Ablation Devices Sales and Value (2012-2017)
        5.1.1 Africa Tumor Ablation Devices Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Tumor Ablation Devices Revenue and Growth Rate (2012-2017)
    5.2 Africa Tumor Ablation Devices Sales and Market Share by Type
    5.3 Africa Tumor Ablation Devices Sales and Market Share by Application
    5.4 Africa Tumor Ablation Devices Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Tumor Ablation Devices Sales Volume by Countries (2012-2017)
        5.4.2 Africa Tumor Ablation Devices Revenue by Countries (2012-2017)
        5.4.3 South Africa Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Tumor Ablation Devices Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Tumor Ablation Devices Sales and Growth Rate (2012-2017)

6 EMEA Tumor Ablation Devices Manufacturers/Players Profiles and Sales Data
    6.1 Ethicon
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Tumor Ablation Devices Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Ethicon Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Karl Storz
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Tumor Ablation Devices Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Karl Storz Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Intuitive Surgical
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Tumor Ablation Devices Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Intuitive Surgical Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Medtronic
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Tumor Ablation Devices Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Medtronic Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Olympus
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Tumor Ablation Devices Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Olympus Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Aesculap
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Tumor Ablation Devices Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Aesculap Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Applied Medical
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Tumor Ablation Devices Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Applied Medical Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 B. Braun Melsungen
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Tumor Ablation Devices Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 B. Braun Melsungen Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 CareFusion
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Tumor Ablation Devices Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 CareFusion Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Conmed
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Tumor Ablation Devices Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Conmed Tumor Ablation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Davol
    6.12 Encision
    6.13 Eon Surgical
    6.14 Gyrus ACMI
    6.15 Integra LifeSciences
    6.16 IMRIS

7 Tumor Ablation Devices Manufacturing Cost Analysis
    7.1 Tumor Ablation Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Tumor Ablation Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Tumor Ablation Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Tumor Ablation Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Tumor Ablation Devices Market Forecast (2017-2022)
    11.1 EMEA Tumor Ablation Devices Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Tumor Ablation Devices Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Tumor Ablation Devices Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Tumor Ablation Devices Price and Trend Forecast (2017-2022)
    11.2 EMEA Tumor Ablation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Tumor Ablation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Tumor Ablation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Tumor Ablation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Tumor Ablation Devices Sales Forecast by Type (2017-2022)
    11.7 EMEA Tumor Ablation Devices Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer